Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: ACR Highlights
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: RA On The Rise In Women
D Scott Cunningham MD, PhD, MDLinx Rheumatology
  See all
juvenileidiopathic arthritis;circulating survuvin Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Circulating survivin indicates severe course of juvenileidiopathic arthritis
Clinical and Experimental Rheumatology Online, 06/03/08
Print     Email This Article     Save in My Library   Free Abstract
Galeotti L et al. – Circulating survivin is expressed in a significant group of patients with juvenile idiopathic arthritis (JIA) being associated to a severe course of the disease. This information may be used to select children with unfavorable prognosis of JIA who are in need of active pharmacologic treatment.

Methods
  • Study to assess the presence of extracellular survivin in pts with JIA
  • Survivin levels were assessed in the circulation of 46 pts with JIA and in the age- and gender-matched controls (n=46) having no inflammatory disease, by ELISA
  • Survivin levels were analyzed with respect to the onset type and the activity of the joint disease
  • The intensity of inflammation and cartilage turnover was measured as levels of IL-6, serum amyloid A protein (SAA), and cartilage oligomeric matrix protein (COMP), respectively

Results
  • The levels of extracellular survivin were significantly higher in JIA vs controls
  • High levels of survivin were detected in 17% of JIA pts
  • High survivin expression was associated with polyarticular onset, active phase of arthritis
  • In contrast, survivin was neither related to the levels of IL-6, SAA, nor to COMP

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.